Glenmark Pharmaceuticals Market Cap ($8.26B USD)
Glenmark Pharmaceuticals Market Cap ($8.26B USD). As of Nov. 19, 2026, Glenmark Pharmaceuticals (GLENMARK) market capitalisation is ₹74306.93 Cr ($8.26B), with 28.49 Cr shares outstanding at a current price of ₹2608.50 on NSE, ranking 146 out of 5368 companies by market cap in our screener. Glenmark Pharmaceuticals operates in the Healthcare sector and is classified as a Large Cap stock.
Market Cap History of Glenmark Pharmaceuticals (Last 10 Years)
GLENMARK market capitalisation from year-end NSE closing prices over the last 10 years. Review GLENMARK P/E comparison to evaluate earnings-based valuation against sector peers.
End of Year Market Cap History — Glenmark Pharmaceuticals
GLENMARK year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see GLENMARK share price screener.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹74306.93 Cr
$8.26B USD
|
₹2608.50 | NSE | +28.17% |
| 2025 |
₹57975.64 Cr
$6.44B USD
|
₹2035.20 | NSE | +26.48% |
| 2024 |
₹45837.56 Cr
$5.09B USD
|
₹1609.10 | NSE | +88.43% |
| 2023 |
₹24326.01 Cr
$2.70B USD
|
₹853.95 | NSE | +101.33% |
| 2022 |
₹12082.53 Cr
$1.34B USD
|
₹424.15 | NSE | -19.75% |
| 2021 |
₹15056.52 Cr
$1.67B USD
|
₹528.55 | NSE | +7.10% |
| 2020 |
₹14058.07 Cr
$1.56B USD
|
₹493.50 | NSE | +42.03% |
| 2019 |
₹9897.62 Cr
$1.10B USD
|
₹347.45 | NSE | -49.87% |
| 2018 |
₹19742.54 Cr
$2.19B USD
|
₹693.05 | NSE | +16.53% |
| 2017 |
₹16942.32 Cr
$1.88B USD
|
₹594.75 | NSE | -33.06% |
| 2016 |
₹25308.80 Cr
$2.81B USD
|
₹888.45 | NSE | -3.63% |
| 2015 |
₹26261.67 Cr
$2.92B USD
|
₹921.90 | NSE | +19.70% |
| 2014 |
₹21940.27 Cr
$2.44B USD
|
₹770.20 | NSE | +44.27% |
| 2013 |
₹15207.50 Cr
$1.69B USD
|
₹533.85 | NSE | +1.00% |
| 2012 |
₹15056.52 Cr
$1.67B USD
|
₹528.55 | NSE | +80.05% |
| 2011 |
₹8362.20 Cr
$929.13M USD
|
₹293.55 | NSE | -18.93% |
| 2010 |
₹10314.95 Cr
$1.15B USD
|
₹362.10 | NSE | +31.27% |
| 2009 |
₹7857.99 Cr
$873.11M USD
|
₹275.85 | NSE | -6.84% |
| 2008 |
₹8434.84 Cr
$937.20M USD
|
₹296.10 | NSE | -50.32% |
| 2007 |
₹16977.93 Cr
$1.89B USD
|
₹596.00 | NSE | +97.78% |
| 2006 |
₹8584.39 Cr
$953.82M USD
|
₹301.35 | NSE | +92.21% |
| 2005 |
₹4466.11 Cr
$496.23M USD
|
₹156.78 | NSE | +29.34% |
| 2004 |
₹3453.13 Cr
$383.68M USD
|
₹121.22 | NSE | +238.89% |
| 2003 |
₹1018.96 Cr
$113.22M USD
|
₹35.77 | NSE | - |